{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T09:28:59Z","timestamp":1784194139531,"version":"3.55.0"},"reference-count":39,"publisher":"American Academy of Pediatrics (AAP)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12,1]]},"abstract":"<jats:p>Background. Universal screening of sexually active adolescents for Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (GC) has been recommended in settings in which prevalence is 2% or greater. Although believed to be above 2%, the prevalence of CT and GC infection in private practice settings has not been clearly established and may affect screening practices.<\/jats:p>\n               <jats:p>Objectives. To determine CT and GC infection prevalence in 2 pediatric private practices.<\/jats:p>\n               <jats:p>Design. Cross-sectional study.<\/jats:p>\n               <jats:p>Setting. Two pediatric private practices in suburban North Carolina.<\/jats:p>\n               <jats:p>Patients. Convenience sample of patients aged 15 to 24 years who were seen from August 1998 through June 1999.<\/jats:p>\n               <jats:p>Main Outcome Measures. Prevalence of CT and GC infection.<\/jats:p>\n               <jats:p>Results. Of 1114 eligible patients, 803 (72%) completed questionnaires and provided urine specimens tested for CT and GC infection using ligase chain reaction assays. Mean age was 17.1 years (standard deviation: 1.8). Most participants were female (63%), white (87%), and from highly educated families (64% of their mothers graduated from college). Sexual activity was reported by 41%. Prevalence of CT infection in all participants was 0.9% (confidence interval [CI]: 0.4%\u20131.8%); in sexually active participants, 2.1% (CI: 0.9%\u20134.3%); in sexually active females, 2.7% (CI: 1.0%\u20135.7%); and in sexually active males, 0.9% (CI: 0.0%\u20135.1%). One case of GC infection was found.<\/jats:p>\n               <jats:p>Conclusions. The prevalence of CT and GC infection in this private practice population was much lower than reported in other settings. Screening recommendations may need to be reassessed if other low prevalence populations are found.<\/jats:p>","DOI":"10.1542\/peds.108.6.e103","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:55:51Z","timestamp":1092441351000},"page":"e103-e103","source":"Crossref","is-referenced-by-count":20,"title":["Prevalence of <i>Chlamydia trachomatis<\/i> and <i>Neisseria gonorrhoeae<\/i> Infection in Pediatric Private Practice"],"prefix":"10.1542","volume":"108","author":[{"given":"Dana","family":"Best","sequence":"first","affiliation":[{"name":"Robert Wood Johnson Clinical Scholars Program, University of North Carolina at Chapel Hill"},{"name":"Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A.","family":"Ford","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina"},{"name":"Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Miller","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina"},{"name":"Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2001,12,1]]},"reference":[{"key":"2021121003493032300_R1","unstructured":"Institute of Medicine. The Hidden Epidemic: Confronting Sexually Transmitted Diseases. Washington, DC: National Academy Press; 1996"},{"key":"2021121003493032300_R2","doi-asserted-by":"crossref","unstructured":"Burstein GR, Gaydos CA, Diener-West M, Howell MR, Zenilman JM, Quinn TC. Incident Chlamydia trachomatis infections among inner-city adolescent females. JAMA.1998;280:521\u2013526","DOI":"10.1001\/jama.280.6.521"},{"key":"2021121003493032300_R3","doi-asserted-by":"crossref","unstructured":"Braverman PK, Biro FM, Brunner RL, Gilchrist MJR, Rauh JL. Screening asymptomatic adolescent males for chlamydia. J Adolesc Health Care.1990;11:141\u2013144","DOI":"10.1016\/0197-0070(90)90024-V"},{"key":"2021121003493032300_R4","doi-asserted-by":"crossref","unstructured":"Marrazzo JM, White CL, Krekeler B, et al. Community-based urine screening for Chlamydia trachomatis with a ligase chain reaction assay. Ann Intern Med.1997;127:796\u2013803","DOI":"10.7326\/0003-4819-127-9-199711010-00004"},{"key":"2021121003493032300_R5","doi-asserted-by":"crossref","unstructured":"Mertz KJ, Levine WC, Mosure DJ, Berman SM, Dorian KJ. Trends in the prevalence of chlamydial infections: the impact of community-wide testing. Sex Transm Dis.1997;24:169\u2013175","DOI":"10.1097\/00007435-199703000-00009"},{"key":"2021121003493032300_R6","doi-asserted-by":"crossref","unstructured":"Stergachis A, Scholes D, Keidrich FE, Sherer DM, Holmes KK, Stamm WE. Selective screening for Chlamydia trachomatis infection in a primary care population of women. Am J Epidemiol.1993;138:143\u2013153","DOI":"10.1093\/oxfordjournals.aje.a116840"},{"key":"2021121003493032300_R7","doi-asserted-by":"crossref","unstructured":"Gaydos CA, Howell MR, Pare B, et al. Chlamydia trachomatis infections in female military recruits. N Engl J Med.1998;339:739\u2013744","DOI":"10.1056\/NEJM199809103391105"},{"key":"2021121003493032300_R8","doi-asserted-by":"crossref","unstructured":"Beck-Sague CM, Farshy CE, Jackson TK, et al. Detection of Chlamydia trachomatis cervical infection by urine tests among adolescent clinics. J Adolesc Health.1998;22:197\u2013204","DOI":"10.1016\/S1054-139X(97)00209-7"},{"key":"2021121003493032300_R9","doi-asserted-by":"crossref","unstructured":"Burstein GR, Waterfield G, Joffe A, et al. Screening for gonorrhea and chlamydia by DNA amplification in adolescents attending middle school health centers. Sex Transm Dis.1998;25:395\u2013402","DOI":"10.1097\/00007435-199809000-00001"},{"key":"2021121003493032300_R10","unstructured":"US Preventive Services Task Force. Screening for chlamydial infection. Am J Prev Med.2001;20:(3S):90\u201394"},{"key":"2021121003493032300_R11","unstructured":"Centers for Disease Control and Prevention. HIV prevention through early detection and treatment of other sexually transmitted diseases\u2014United States recommendations of the Advisory Committee for HIV and STD Prevention. MMWR Morb Mortal Wkly Rep.1997;47(RR-12):1\u201324"},{"key":"2021121003493032300_R12","unstructured":"National Committee for Quality Assurance. HEDIS 2000. Vol. 2. Washington, DC: National Committee for Quality Assurance; 2000:68\u201370"},{"key":"2021121003493032300_R13","doi-asserted-by":"crossref","unstructured":"Mangione-Smith R, O\u2019Leary J, McGlynn EA. Health and cost-benefits of chlamydia screening in young women. Sex Transm Dis.1999;26:309\u2013316","DOI":"10.1097\/00007435-199907000-00001"},{"key":"2021121003493032300_R14","unstructured":"Southwick K, Bloom D, Sanchez V, McDonald M, Leone P. Barriers to routine chlamydia testing of adolescent women in private pediatric practices, Wake County, North Carolina, 1998 [abstract]. Presented at: National STD Conference; December 7, 1998; Dallas, TX"},{"key":"2021121003493032300_R15","unstructured":"Southwick KL, Sanchez V, Bloom D, Eng E, Leone PA. Barriers to obtaining sexual histories from teens in private pediatrics and family practice offices, Wake County, NC [abstract]. Presented at: International Society for STD Research; July 13, 1999; Denver, CO"},{"key":"2021121003493032300_R16","unstructured":"Centers for Disease Control and Prevention. Chlamydia trachomatis genital infections\u2014United States, 1995. MMWR Morb Mortal Wkly Rep.1997;46:193\u2013198"},{"key":"2021121003493032300_R17","doi-asserted-by":"crossref","unstructured":"Scholes D, Stergachis A, Heidrich FE, Andrilla H, Holmes K, Stamm W. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med.1996;334:1362\u20131365","DOI":"10.1056\/NEJM199605233342103"},{"key":"2021121003493032300_R18","doi-asserted-by":"crossref","unstructured":"Nelson ME. Prevalence of Chlamydia trachomatis infection among women in a multiphysician primary care practice. Am J Prev Med.1992;8:298\u2013302","DOI":"10.1016\/S0749-3797(18)30795-5"},{"key":"2021121003493032300_R19","doi-asserted-by":"crossref","unstructured":"Addiss DG, Vaughn ML, Golubjatnikov R, Pfister J, Kurtycz D, Davis J. Chlamydia trachomatis infection in women attending urban Midwestern family planning and community health clinics: risk factors, selective screening, and evaluation of non-culture techniques. Sex Transm Dis.1990;17:138\u2013146","DOI":"10.1097\/00007435-199007000-00006"},{"key":"2021121003493032300_R20","doi-asserted-by":"crossref","unstructured":"Mertz KJ, Levine WC, Mosure DJ, Berman SM, Dorian KJ, Hadgu A. Screening women for gonorrhea: demographic screening criteria for general clinical use. Am J Public Health.1997;87:1535\u20131538","DOI":"10.2105\/AJPH.87.9.1535"},{"key":"2021121003493032300_R21","unstructured":"Stata Corp. Stata Statistical Software: Release 6.0. College Station, TX: Stata Corporation; 1999"},{"key":"2021121003493032300_R22","doi-asserted-by":"crossref","unstructured":"Mosure DJ, Berman S, Fine D, Delisle S, Cates W, Boring JR III. Genital chlamydia infections in sexually active female adolescents: do we really need to screen everyone?J Adolesc Health.1997;20:6\u201313","DOI":"10.1016\/S1054-139X(96)00157-7"},{"key":"2021121003493032300_R23","unstructured":"Ripa T. Epidemiologic control of genital Chlamydia trachomatis infections. Scand J Infect Dis.1990;69(suppl):157\u2013167"},{"key":"2021121003493032300_R24","doi-asserted-by":"crossref","unstructured":"Cohen DA, Nsuami M, Martin DH, Farley TA. Repeated school-based screening for sexually transmitted diseases: a feasible strategy for reaching adolescents. Pediatrics.1999;104:1281\u20131285","DOI":"10.1542\/peds.104.6.1281"},{"key":"2021121003493032300_R25","doi-asserted-by":"crossref","unstructured":"Miller WC, Hoffman IF, Owen-O\u2019Dowd J, et al. Selective screening for chlamydial infection: which criteria to use?Am J Prev Med.2000;18:115\u2013122","DOI":"10.1016\/S0749-3797(99)00146-4"},{"key":"2021121003493032300_R26","unstructured":"Centers for Disease Control and Prevention. Chlamydia screening practices of primary-care providers\u2014Wake County, North Carolina, 1996. MMWR Morb Mortal Wkly Rep.1997;46:819\u2013822"},{"key":"2021121003493032300_R27","doi-asserted-by":"crossref","unstructured":"Aral SO. The social context of syphilis persistence in the southeastern United States. Sex Transm Dis.1996;23:9\u201315","DOI":"10.1097\/00007435-199601000-00005"},{"key":"2021121003493032300_R28","doi-asserted-by":"crossref","unstructured":"Nelson HD, Helfand M. Screening for chlamydial infection. Am J Prev Med.2001;20(3S):95\u2013107","DOI":"10.1016\/S0749-3797(01)00253-7"},{"key":"2021121003493032300_R29","doi-asserted-by":"crossref","unstructured":"Ellen JM, Kohn RP, Bolan GA, Shiboski S, Krieger N. Socioeconomic differences in sexually transmitted disease rates among black and white adolescents, San Francisco, 1990 to 1992. Am J Public Health.1995;85:1546\u20131548","DOI":"10.2105\/AJPH.85.11.1546"},{"key":"2021121003493032300_R30","unstructured":"Centers for Disease Control and Prevention. Guidelines for treatment of sexually transmitted disease. MMWR Morb Mortal Wkly Rep. 1998;1998;:47(RR-1):1\u2013118"},{"key":"2021121003493032300_R31","doi-asserted-by":"crossref","unstructured":"Boyer CB, Shafer MA, Teitle E, Wibblesman CJ, Seeberg D, Schachter J. Sexually transmitted diseases in a health maintenance organization teen clinic: associations of race, partner\u2019s age, and marijuana use. Arch Pediatr Adolesc Med.1999;153:838\u2013844","DOI":"10.1001\/archpedi.153.8.838"},{"key":"2021121003493032300_R32","doi-asserted-by":"crossref","unstructured":"Ellen JM, Hessol NA, Kohn RP, Bolan GA. An investigation of geographic clustering of repeat cases of gonorrhea and chlamydial infection in San Francisco, 1989\u20131993: evidence for core groups. J Infect Dis.1997;175:1519\u20131522","DOI":"10.1086\/516491"},{"key":"2021121003493032300_R33","doi-asserted-by":"crossref","unstructured":"Magder LS, Harrison HR, Ehret JM, Anderson TS, Judson FN. Factors related to genital Chlamydial trachomatis and its diagnosis by culture in a sexually transmitted disease clinic. Am J Epidemiol.1988;28:298\u2013308","DOI":"10.1093\/oxfordjournals.aje.a114970"},{"key":"2021121003493032300_R34","doi-asserted-by":"crossref","unstructured":"Mertz KJ, McQuillan GM, Levine WC, et al. A pilot study of the prevalence of chlamydial infection in a national household survey. Sex Transm Dis.1998;25:225\u2013228","DOI":"10.1097\/00007435-199805000-00001"},{"key":"2021121003493032300_R35","doi-asserted-by":"crossref","unstructured":"Cohen DA, Nsuami M, Etame RB, et al. A school-based chlamydia control program using DNA amplification technology. Pediatrics. 1998;101(1). Available at: http:\/\/www.pediatrics.org\/cgi\/content\/full\/101\/1\/e1","DOI":"10.1542\/peds.101.1.e1"},{"key":"2021121003493032300_R36","doi-asserted-by":"crossref","unstructured":"Ciemins EL, Borenstien LA, Dyer IE, et al. Comparisons of cost and accuracy of DNA probe test and culture for the detection of Neisseria gonorrhoeae in patients attending public sexually transmitted disease clinics in Los Angeles County. Sex Transm Dis.1997;24:422\u2013428","DOI":"10.1097\/00007435-199708000-00007"},{"key":"2021121003493032300_R37","doi-asserted-by":"crossref","unstructured":"Carroll KC, Aldeen WE, Morrison M, Anderson R, Lee D, Mottice S. Evaluation of the Abbott LCx ligase chain reaction assay for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urine and genital swab specimens from a sexually transmitted disease clinic population. J Clin Microbiol.1998;36:1630\u20131633","DOI":"10.1128\/JCM.36.6.1630-1633.1998"},{"key":"2021121003493032300_R38","unstructured":"Abbott Laboratories, Diagnostics Division. Chlamydia trachomatis Assay [package insert]. Abbott Park, IL: Abbott Laboratories; 1996"},{"key":"2021121003493032300_R39","unstructured":"Abbott Laboratories, Diagnostics Division. Neisseria gonorrhoeae Assay [package insert]. Abbott Park, IL: Abbott Laboratories; 1996"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/108\/6\/e103\/1113333\/pe120100e103.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/108\/6\/e103\/1113333\/pe120100e103.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T11:04:48Z","timestamp":1639134288000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/108\/6\/e103\/63617\/Prevalence-of-Chlamydia-trachomatis-and-Neisseria"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,12,1]]},"references-count":39,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2001,12,1]]},"published-print":{"date-parts":[[2001,12,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.108.6.e103","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,12,1]]}}}